Inhibitor | Structure | Research status and clinical trials | Type of tumor | RBP | reference |
1632 | pre-clinical | Hepatocellular carcinoma | LIN8 | [224] | |
VPC-80051 | pre-clinical | Castration-Resistant Prostate Cancer | hnRNPA1 | [225] | |
L-norleucine | pre-clinical | breast cancer | hnRNPA2/B1 | [226] | |
CMLD-2 | pre-clinical | colon cancer | HuR | [227] | |
Resveratrol | Phase II | Melanoma | RBFox2 | [94] | |
MS-444– | pre-clinical | Colorectal Cancer | HuR | [228] | |
C1632 | pre-clinical | Multiple tumors | LIN8 | [51] | |
BTYNB | pre-clinical | Melanoma and Ovarian Cancer | IMP1 | [229] |